The Pharmacy Industry in Orkland: Current Status and Future Prospects

The pharmacy industry in Orkland has shown stable growth and an increasing number of employees over the past few years. There are 5 pharmacy businesses registered in the municipality, with a combined revenue of 153.9 million NOK in 2025. The number of employees has increased from 31 in 2016 to 49 in 2026, with an average annual growth of 4.3%. The industry is dominated by AS companies, which account for all registered businesses. The most significant geographical centers are Orkanger and Fannrem, where pharmacies have shown variable, but often high, revenue growth.

Economic trends

Revenue has grown from 60.0 million NOK in 2016 to 153.9 million NOK in 2025, with an average annual growth of 8.2%. The most significant increase occurred in 2018 (+56.9%), while a decline was recorded in 2019 (-7.6%). Number of employees has grown continuously, with an increase of 19.4% from 2016 to 2017, and an average annual growth of 4.3% since. EBITDA margins range from 5-7%, and average gross profit is 12,225% (Orkanger) to 31,684% (Fannrem).

Registered companies

There are 5 pharmacy businesses registered in Orkland, all with AS organizational form. The most important companies are:

All companies are in operation, and none have registered bankruptcy.

Geographic distribution

Pharmacies are distributed across two main areas:

1. Orkanger (4 companies, 41 employees):

• Revenue: 122.1 million NOK
• EBITDA: 6.9 million NOK
• Average income per employee: 3.0 million NOK

1. Fannrem (1 company, 8 employees):

• Revenue: 19.3 million NOK
• EBITDA: 1.4 million NOK
• Average income per employee: 2.5 million NOK

Orkanger accounts for 79% of the industry's total revenue, while Fannrem has higher percentage growth (10% in 2025).

Operational efficiency and dynamics

The industry has shown itself to be stable, with no bankruptcy registrations among the 5 companies. The most significant operational results are:

• Vitusapotek Orkedalen has the highest EBITDA (3.7 M) and highest revenue (59.1 M)
• Boots Apotek Orkla has the lowest EBITDA margin (1%) and zero growth in 2025
• Fannrem pharmacy has the highest gross profit margin (31,684%) and highest revenue growth (10% in 2025)

Operational results show that larger companies have better stabilization, while newer companies (such as Apotek 1 Fannrem, founded in 2021) may have higher growth potential.

Future perspectives

The data indicate that the pharmacy industry in Orkland has good growth potential, especially in Orkanger where there is establishment of more companies. The high gross profit margins (12,225-31,684%) show that the industry has good economic stability. For entrepreneurs, this can be an attractive sector, with particular opportunities in Fannrem where there is low competition and high revenue growth. SmartGrunder can help analyze potential locations in the municipality for pharmacy businesses.

The pharmacy industry in Orkland shows clear signs of stable growth and increasing operational efficiency. With 5 companies, high revenue, and good economic stability, this is an attractive sector for both existing businesses and new entrepreneurs. The geographical centers in Orkanger and Fannrem each have their own strengths, and the data show that there are opportunities for further development. SmartGrunder can help identify optimal locations and strategies for pharmacy businesses in the municipality.